The evolution of therapeutic options in ITP


The evolution of therapeutic options in ITP

Title: The Evolution of Therapeutic Options in ITP

Release Date: December 1, 2007
Expiration Date: December 31, 2008
(CME credit is no longer available for this activity)

Originally presented at Cytopenias in 2007
San Diego, CA, October 5, 2007

Agenda:

The Pathophysiology of Thrombopoiesis (9:23) Amy Geddis, MD, PhD
Thrombopoietic-like Agents (23:39) Terry Gernsheimer, MD
Mechanisms of Effects of IVIg and
Intravenous Anti-D in ITP (11:20)
Alan H. Lazarus, PhD
Clinical Effects of IVIg and Anti-D in ITP (9:26) James B. Bussel, MD
Clinical Effects of Rituximab: Targeting of B Cells (9:43) Douglas B. Cines, MD

 




Jointly Sponsored by:

dannemiller

 

 

 

jwa





This program is only available to registered users.
If you have already registered, please login Otherwise, please click here to register first.

X
click me